Effects of Multiple-target Anti-microRNA Antisense Oligodeoxyribonucleotides on Proliferation and Migration of Gastric Cancer Cells |
Xu, Ling
(Department of Gastroenterology, Tenth People's Hospital of Tongji University)
Dai, Wei-Qi (Department of Gastroenterology, Tenth People's Hospital of Tongji University) Xu, Xuan-Fu (Department of Gastroenterology, Tenth People's Hospital of Tongji University) Wang, Fan (Department of Gastroenterology, Tenth People's Hospital of Tongji University) He, Lei (Department of Gastroenterology, Tenth People's Hospital of Tongji University) Guo, Chuan-Yong (Department of Gastroenterology, Tenth People's Hospital of Tongji University) |
1 | Bartels CL and Tsongalis GJ (2009). MicroRNAs: novel biomarkers for human cancer. Clin Chem, 55, 623-31. DOI |
2 | Chen CF, Ridzon DA and Broomer AJ, et al (2005). Real- time quantification of microRNAs by stem-loop RT- PCR. Nucleic Acids Res, 33, e179. DOI |
3 | Chen Y, Stallings RL (2007). Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res, 67, 976-83. DOI |
4 | Denli AM, Tops BJ, Plasterk PH, et al (2004). Processing of primary microRNAs by the microprocessor complex. Nature, 432, 231-5. DOI |
5 | Esquela-Kerscher A and Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69. DOI |
6 | Ferdin J, Kunej T and Calin GA (2010). Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling. Technol Cancer Res Treat, 9, 123-38. DOI |
7 | Gregory RI, Yan K, Amuthan G, et al (2004). The microprocessor complex mediates the genesis of microRNAs. Nature, 432, 235-40. DOI |
8 | Krutzfeldt J, Rajewsky N, Braich R, et al (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-9. DOI |
9 | Lee EJ, Gusev Y, Jiang J, et al (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer, 120, 1046-54. |
10 | Liu W, Mao SY and Zhu WY (2007). Impact of tiny miRNAs on cancers. World J Gastroenterol, 13, 497-502. DOI |
11 | Orom UA, Kauppinen S, Lund AH (2006). LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene, 372, 137-41. DOI |
12 | Schetter AJ, Leung SY, Sohn JJ, et al (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-36. DOI |
13 | Wang V and Wu W (2009). MicroRNA-based therapeutics for cancer. BioDrugs, 23, 15-23. DOI |
14 | Li C, Feng Y, Coukos G, et al (2009). Therapeutic microRNA strategies in human cancer. AAPS J, 11, 747-57. DOI |
15 | Lu Y, Xiao J, Lin H, et al (2009). A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res, 37, e24. DOI |
16 | Wagner RW (1994). Gene inhibition using antisense oligodeoxynucleotides. Nature, 372, 333-5. DOI |
17 | Yanaihara N, Caplen N, Bowman E, et al (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-98. DOI ScienceOn |
18 | Weiler J, Hunziker J, Hall J (2006). Anti-miRNA-oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease. Gene Ther, 13, 496-502. DOI ScienceOn |
19 | Xiao B, Guo J, Miao Y, et al (2009). Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta, 400, 97-102. DOI |